Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Diphenhydramine
Drug ID BADD_D00686
Description Diphenhydramine - perhaps known most commonly as its brand name formulation Benadryl - is a first-generation H1 receptor antihistamine that is used extensively for the treatment of seasonal allergies, insect bites and stings, and rashes [L5263, L5266, L5269, F3379]. However, it also has antiemetic, antitussive, hypnotic, and antiparkinson properties [L5269, F3352]. As histamine receptors exist both peripherally and in the central nervous system, diphenhydramine has been shown to cause sedation due to its competitive antagonism of histamine H1 receptors within the central nervous system [L5263, L5266, L5269, F3379, A174541]. While its use in allergy therapy can sometimes fall out of favor due to its sedative effect, diphenhydramine has been repurposed for use within many non-prescription over-the-counter sleep aids and cough-and-cold medications that have been marketed for "night time" use [L5263, L5281, L5287]. Diphenhydramine is also used in combination with [DB14132] as the anti-nausea drug [DB00985] where it is utilized primarily for its antagonism of H1 histamine receptors within the vestibular system [A1540]. Diphenhydramine has also been shown to be implicated in a number of neurotransmitter systems that affect behaviour including dopamine, norepinephrine, serotonin, acetylcholine, and opioid [A1539]. As a result, diphenhydramine is being investigated for its anxiolytic and anti-depressant properties.
Indications and Usage For the treatment of symptoms associated with Vertigo/Meniere's disease, nausea and vomiting, motion sickness and insect bite.
Marketing Status Prescription; Discontinued
ATC Code D04AA32; R06AA02
DrugBank ID DB01075
KEGG ID D00300
MeSH ID D004155
PubChem ID 3100
TTD Drug ID D01FGR
NDC Product Code 52119-012; 76168-065
Synonyms Diphenhydramine | Benzhydramine | Diphenylhydramine | Diphenylhydramin | 2-Diphenylmethoxy-N,N-dimethylethylamine | Benhydramin | Benadryl | Benylin | Diphenhydramine Citrate | Citrate, Diphenhydramine | Diphenhydramine Citrate (1:1) | Diphenhydramine Hydrochloride | Hydrochloride, Diphenhydramine | Dormin | Allerdryl | Dimedrol
Chemical Information
Molecular Formula C17H21NO
CAS Registry Number 58-73-1
SMILES CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Vision blurred17.17.01.010; 06.02.06.007--
Vomiting07.01.07.003--
Weight decreased13.15.01.005--
Wheezing22.03.01.0090.000505%
White blood cell count decreased13.01.06.012--
White blood cell count increased13.01.06.013--Not Available
Withdrawal syndrome19.07.02.005; 08.06.02.0120.002021%Not Available
Mental status changes19.07.01.0010.008084%Not Available
Mobility decreased17.02.05.018; 15.03.01.003; 08.01.03.0300.000505%Not Available
Urosepsis20.08.02.002; 11.01.11.0050.000758%Not Available
Peripheral swelling08.01.03.053; 02.05.04.015--Not Available
Brain oedema17.07.02.003; 12.01.10.0100.000989%
Brain death08.04.01.004; 17.02.03.0030.000857%Not Available
Emotional distress19.04.02.008--Not Available
Impatience19.05.01.0140.000132%Not Available
Deep vein thrombosis24.01.02.003--Not Available
Haemodynamic instability24.03.02.0060.000758%Not Available
Pruritus generalised23.03.12.0030.000505%Not Available
Musculoskeletal stiffness15.03.01.005--Not Available
Skin burning sensation23.03.03.021; 17.02.06.0090.000505%Not Available
Foetal death18.01.02.003; 08.04.01.0110.000659%
Gaze palsy17.02.05.044; 06.05.02.0140.000198%Not Available
Paraesthesia oral17.02.06.008; 07.05.03.0030.000758%Not Available
Cognitive disorder19.21.02.001; 17.03.03.0030.001010%
Major depression19.15.01.0030.000758%Not Available
Ocular icterus09.01.01.007; 06.08.03.009; 01.06.04.0070.000505%Not Available
Pulseless electrical activity02.03.04.0200.002779%Not Available
Hypoperfusion24.06.02.0190.000505%Not Available
Restless legs syndrome17.02.07.008; 15.05.03.0120.002021%Not Available
Ventricular dysfunction02.04.02.0050.001010%Not Available
The 10th Page    First    Pre   10 11 12    Next   Last    Total 12 Pages